Upgrade to SI Premium - Free Trial

Quest Diagnostics (DGX) PT Raised to $165 at Leerink Partners

October 23, 2024 6:05 AM
Leerink Partners analyst Michael Cherny raised the price target on Quest Diagnostics (NYSE: DGX) to $165.00 (from $160.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles